Table 1.
Overview of patients’ details.
| Subject | Gender | Age | Disease Onset | Medication |
|---|---|---|---|---|
| * PD 1 | M | 58 | 50 | Levodopa, Trihexyphenidyl |
| * PD 2 | M | 69 | 64 | Rasagiline, propranolol |
| * PD 3 | M | 67 | 63 | Trihexyphenidyl |
| * PD 4 | F | 81 | 76 | Levodopa-Carbidopa, metoprolol tartrate |
| * PD 5 | F | 62 | 60 | Levodopa |
| Ϯ PD 6 | M | 49 | 47 | Levodopa-Carbidopa, ropinirole hydrochloride |
| Ϯ PD 7 | M | 71 | 71 | - |
| Ϯ PD 8 | F | 43 | 40 | Trihexyphenidyl, ropinirole hydrochloride |
| Ϯ PD 9 | M | 78 | 76 | Levodopa-Carbidopa, Rasagiline, perindopril, omeprazole, pravastatin |
| Ϯ PD 10 | M | 68 | 60 | Levodopa-Carbidopa |
| * ET 1 | M | 45 | Childhood | - |
| * ET 2 | F | 81 | Childhood | - |
| * ET 3 | M | 85 | Childhood | Propranolol |
| * ET 4 | M | 65 | Teenager | - |
| * ET 5 | F | 51 | Childhood | - |
| Ϯ ET 6 | M | 49 | 40 | Propranolol |
| Ϯ ET 7 | M | 54 | Teenager | - |
| Ϯ ET 8 | M | 70 | Childhood | - |
| Ϯ ET 9 | M | 64 | Teenager | - |
| Ϯ ET 10 | M | 55 | Teenager | - |
(*) Training set. (Ϯ) Validation group. M = Male; F = Female.